HCT-116 In Vitro Comet-based DNA Damage Assay (Apoptosis )

CAT#: ITS-1022-YF5922
Target Cell Organism: Human
Target Cell Name: HCT-116
Assay Type: Detection of Apoptosis Assays
Assay Overview
This assay is to provide HCT-116-based In Vitro Comet-based DNA Damage Assay (Apoptosis ) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
HCT-116
Target Cell Organism
Human
Target Cell Background
HCT 116 cell line was isolated from the colon of an adult male with colon cancer. It has a mutation in codon 13 of the ras proto-oncogene and can be used as a positive control for PCR assays of mutation in this codon.
Related Diseases
Colorectal Adenocarcinoma; Colon Cancer
Research Area
Oncology
Assay Name
In Vitro Comet-based DNA Damage Assay (Apoptosis )
Short Description
HCT-116-cell based In Vitro Comet-based DNA Damage Assay (Apoptosis )
Assay Description
In the comet assay, upon incubating cancer cells with a chemical compound or treatment with radiation, cells are attached on microscopic slides covered with agarose and then subjected to gel electrophoresis following cell lysis. During electrophoresis, damaged DNA is moved away from the nucleus and undamaged DNA is retained in the nucleus, forming a comet-like appearance. The length of the tail and size of the head of comet are considered in evaluating DNA damage.
Assay Type
Detection of Apoptosis Assays
Assay Type Details
Apoptosis (programmed cell death) plays a vital role in embryonic development, homeostasis, functioning of immune system and wound repair. The ability to evade induction of apoptosis has been used by cancer cells to survive against host defense mechanisms. The molecular mechanisms involved in cancer cell apoptosis have been well documented and it involves certain biochemical events such as DNA fragmentation, chromatin condensation, cell organelle degradation and protein cleavage, etc. The extrinsic and intrinsic (mitochondrial) pathways are the two major pathways involved in apoptosis. With the available techniques and assays, a number of apoptosis inducing agents (natural compounds, synthetic compounds, nano-formulations, peptides and enzymes) in many cancer cells have been identified. Selection of an assay for apoptosis detection is based on factors such as apoptotic pathway, nature of drug, cell type being used and the method of analysis.
Assay Subtype
DNA Fragmentation and Damage Assays
Assay MOA
DNA Damage Assay
For Research Use Only | Not For Clinical Use
Online Inquiry